Kian Keyashian, MD, a clinical assistant professor of medicine in the Division of Gastroenterology and Hepatology at Stanford University in Redwood City, Calif., discusses the significance of one of the few publications examining the safety and efficacy of combination treatment with an immunomodulator and biologic therapy in older patients with Crohn’s disease.
Study
Singh S Stitt LW, Zou G, et al. Early combined immunosuppression may be effective and safe in older